scientists are also working on ultra-extended-performing GLP-one analogs that could have to have dosing only once per month or simply much less frequently. These prolonged-release variations could make it even simpler to stick with taking GLP-1s.  These variances can affect which peptide is ideal for a specific particular person, according to the